This is awesome news!
In the first federal-government-approved clinical trial of its kind in the U.S., patients with amyotrophic lateral sclerosis (ALS) will be treated with their own stem cells.
The aim is to hopefully slow the progress of the fatal, neurodegenerative disease.
TCA Cellular Therapy of Covington, a privately held stem-cell research and development company, has signed up the first of six participants for Phase I of the trial recently approved by the U.S. Food and Drug Administration.
2theadvocate.com | Features | Clinic to participate in stem-cell trial — Baton Rouge, LA
